财经快讯|富祥药业与绿客盟等签订战略合作协议,涉及微生物蛋白研发及供货
5月18日召开的首届全国微生物蛋白技术创新及产业发展大会上,富祥药业(300497.SZ)与香港绿客盟有限公司、马来西亚Ultimeat(M)Sdn Bhd签订战略合作协议。
界面新闻记者在现场了解到,上述合作协议涉及成立合资公司,合作研发和微生物蛋白供货等,两家合作方分别计划根据产品研发进度,三年内拟采购富祥微生物蛋白共计12000吨。
2023年度,富祥药业通过自主研发及国际合作,完成了镰刀菌发酵工艺制造微生物蛋白的产业化生产,目前已建成1200吨微生物蛋白生产线,并已投入生产,年产20000吨蛋白生产线正在建设中。
Statement:
The content of this article does not represent the views of fxgecko website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!
Cổ phiếu thép VGS áp sát đỉnh lịch sử, dự án gần 6.300 tỷ đồng tại Vĩnh Phúc có tiến triển mới Theo nguoiquansat.vn
DBG Markets|黄金强势突破2400美元!多机构预测:金价还会涨!
Related News
![](/images/page_blank@2x.png)